Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.

Expression of the growth hormone secretagogue receptor in pituitary adenomas and other neuroendocrine tumors.

Synthetic GH secretagogues (GHSs; GH-releasing peptides and their nonpeptide mimetics) stimulate GH release, activate the hypothalamo-pituitary-adrenal axis, and release PRL in vivo. Patients with acromegaly show an exuberant GH response to GHSs, whereas patients with pituitary-dependent ACTH-secret...

Full description

Bibliographic Details
Main Authors:	Korbonits, M, Jacobs, R, Aylwin, S, Burrin, J, Dahia, P, Monson, J, Honegger, J, Fahlbush, R, Trainer, P, Chew, S, Besser, G, Grossman, AB
Format:	Journal article
Language:	English
Published:	1998

Similar Items

The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin.
by: Korbonits, M, et al.
Published: (1999)

The expression of the growth hormone secretagogue receptor ligand ghrelin in normal and abnormal human pituitary and other neuroendocrine tumors.
by: Korbonits, M, et al.
Published: (2001)

The effect of growth hormone secretagogues on the release of growth hormone-releasing hormone, somatostatin, vasopressin, and corticotrophin-releasing hormone from the rat hypothalamus in vitro
by: Korbonits, M, et al.
Published: (1998)

The growth hormone secretagogue receptor.
by: Korbonits, M, et al.
Published: (1999)

Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion.
by: Skelly, R, et al.
Published: (2000)

The relationship between steroidogenic factor 1 and DAX-1 expression and in vitro gonadotropin secretion in human pituitary adenomas.
by: Aylwin, S, et al.
Published: (2001)

The release of leptin and its effect on hormone release from human pituitary adenomas.
by: Korbonits, M, et al.
Published: (2001)

Hexarelin as a test of pituitary reserve in patients with pituitary disease.
by: Korbonits, M, et al.
Published: (1999)

The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants.
by: Korbonits, M, et al.
Published: (1999)

Mutational analysis of ghrelin and the growth hormone secretagogue receptor
by: Gueorguiev, M, et al.
Published: (2004)

Benzodiazepines attenuate the pituitary-adrenal responses to corticotrophin-releasing hormone in healthy volunteers, but not in patients with Cushing's syndrome.
by: Korbonits, M, et al.
Published: (1995)

The pathology of pituitary adenomas from a clinical perspective.
by: Dworakowska, D, et al.
Published: (2011)

Leptin in pituitary adenomas--a novel paracrine regulatory system.
by: Korbonits, M, et al.
Published: (2001)

Stereotactic radiosurgery XVI: a treatment for previously irradiated pituitary adenomas.
by: Swords, F, et al.
Published: (2003)

Rapid desensitisation of the GH secretagogue (ghrelin) receptor to hexarelin in vitro.
by: Orkin, R, et al.
Published: (2003)

Growth hormone deficiency and replacement in patients with treated Cushing's Disease, prolactinomas and non-functioning pituitary adenomas: effects on body composition, glucose metabolism, lipid status and bone mineral density.
by: Colson, A, et al.
Published: (2006)

A genetic study of the ghrelin and growth hormone secretagogue receptor (GHSR) genes and stature.
by: Gueorguiev, M, et al.
Published: (2009)

Novel molecular aspects of pituitary adenomas.
by: Hubina, E, et al.
Published: (2005)

Second brain tumour after treatment for pituitary adenoma.
by: Wass, J, et al.
Published: (1992)

Mutation and expression analysis of the p27/kip1 gene in corticotrophin-secreting tumours.
by: Dahia, P, et al.
Published: (1998)

NITRIC-OXIDE AS A NOVEL REGULATOR OF NEUROENDOCRINE FUNCTION - CONTROL OF CORTICOTROPIN-RELEASING HORMONE-41 RELEASE FROM THE RAT HYPOTHALAMUS INVITRO
by: Costa, A, et al.
Published: (1992)

Insulin-like growth factor-I and- II in combination inhibit the release of growth hormone-releasing hormone from the rat hypothalamus in vitro.
by: Korbonits, M, et al.
Published: (1996)

PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas
by: Giulia Cossu, et al.
Published: (2023-09-01)

A comparison of the effects of human and ovine corticotropin-releasing hormone on the pituitary-adrenal axis.
by: Trainer, P, et al.
Published: (1995)

Leptin levels do not change acutely with food administration in normal or obese subjects, but are negatively correlated with pituitary-adrenal activity.
by: Korbonits, M, et al.
Published: (1997)

Clinical, genetic and molecular characterization of patients with familial isolated pituitary adenomas (FIPA).
by: Chahal, H, et al.
Published: (2010)

AIP mutation in pituitary adenomas in the 18th century and today.
by: Chahal, H, et al.
Published: (2011)

The pathophysiology of pituitary adenomas.
by: Dworakowska, D, et al.
Published: (2009)

Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors.
by: Dahia, P, et al.
Published: (1996)

Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
by: Kaltsas, G, et al.
Published: (2001)

Differential gene expression in pituitary adenomas by oligonucleotide array analysis.
by: Morris, D, et al.
Published: (2005)

Oncogene-induced senescence in pituitary adenomas and carcinomas.
by: Alexandraki, K, et al.
Published: (2012)

Brief Report: AIP Mutation in Pituitary Adenomas in the 18th Century and Today.
by: Chahal, H, et al.
Published: (2011)

Expression of glucocorticoid receptor gene isoforms in corticotropin-secreting tumors.
by: Dahia, P, et al.
Published: (1997)

Neuroprotective actions of ghrelin and growth hormone secretagogues
by: Laura M. Frago, et al.
Published: (2011-09-01)

MRI of pancreatic neuroendocrine tumours.
by: Owen, N, et al.
Published: (2001)

CT appearance of the adrenal glands in adrenocorticotrophic hormone-dependent Cushing's syndrome.
by: Sohaib, SA, et al.
Published: (1999)

Pyridostigmine partially reverses dexamethasone-induced inhibition of the growth hormone response to growth hormone-releasing hormone.
by: Trainer, P, et al.
Published: (1992)

Calcium and calmodulin mediation of growth hormone-releasing hormone release from the rat hypothalamus in vitro.
by: Honegger, J, et al.
Published: (1991)

The effect of enkephalin analogue on pituitary hormone release in human obesity.
by: Finer, N, et al.
Published: (1987)